Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.61
CTRX's Cash to Debt is ranked lower than
59% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.53 vs. CTRX: 0.61 )
Ranked among companies with meaningful Cash to Debt only.
CTRX' s 10-Year Cash to Debt Range
Min: 0.26   Max: No Debt
Current: 0.61

Equity to Asset 0.57
CTRX's Equity to Asset is ranked higher than
82% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.36 vs. CTRX: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
CTRX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.91
Current: 0.57

0.3
0.91
F-Score: 7
Z-Score: 4.42
M-Score: -2.16
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 2.70
CTRX's Operating margin (%) is ranked higher than
52% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.70 vs. CTRX: 2.70 )
Ranked among companies with meaningful Operating margin (%) only.
CTRX' s 10-Year Operating margin (%) Range
Min: -32.17   Max: 19.04
Current: 2.7

-32.17
19.04
Net-margin (%) 1.51
CTRX's Net-margin (%) is ranked higher than
52% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. CTRX: 1.51 )
Ranked among companies with meaningful Net-margin (%) only.
CTRX' s 10-Year Net-margin (%) Range
Min: -41.12   Max: 16.86
Current: 1.51

-41.12
16.86
ROE (%) 6.64
CTRX's ROE (%) is ranked lower than
52% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.50 vs. CTRX: 6.64 )
Ranked among companies with meaningful ROE (%) only.
CTRX' s 10-Year ROE (%) Range
Min: -128.72   Max: 22.93
Current: 6.64

-128.72
22.93
ROA (%) 3.74
CTRX's ROA (%) is ranked higher than
55% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.05 vs. CTRX: 3.74 )
Ranked among companies with meaningful ROA (%) only.
CTRX' s 10-Year ROA (%) Range
Min: -43.46   Max: 12.8
Current: 3.74

-43.46
12.8
ROC (Joel Greenblatt) (%) 225.97
CTRX's ROC (Joel Greenblatt) (%) is ranked higher than
75% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 76.39 vs. CTRX: 225.97 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CTRX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -131.7   Max: 665.61
Current: 225.97

-131.7
665.61
Revenue Growth (3Y)(%) 43.60
CTRX's Revenue Growth (3Y)(%) is ranked higher than
92% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. CTRX: 43.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CTRX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -12.5   Max: 143.3
Current: 43.6

-12.5
143.3
EBITDA Growth (3Y)(%) 51.60
CTRX's EBITDA Growth (3Y)(%) is ranked higher than
95% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CTRX: 51.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CTRX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 56.8
Current: 51.6

0
56.8
EPS Growth (3Y)(%) 33.20
CTRX's EPS Growth (3Y)(%) is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.40 vs. CTRX: 33.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CTRX' s 10-Year EPS Growth (3Y)(%) Range
Min: -9.4   Max: 55.8
Current: 33.2

-9.4
55.8
» CTRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

CTRX Guru Trades in Q2 2014

Jim Simons 399,770 sh (New)
Wallace Weitz 748,620 sh (New)
Diamond Hill Capital 406,774 sh (+164.24%)
Manning & Napier Advisors, Inc 4,822,470 sh (+145.55%)
Paul Tudor Jones 15,662 sh (+133.20%)
Joel Greenblatt 12,535 sh (+29.71%)
Steven Cohen 310,700 sh (unchged)
Vanguard Health Care Fund 4,221,183 sh (unchged)
Louis Moore Bacon 150,000 sh (unchged)
Louis Moore Bacon Sold Out
Lee Ainslie Sold Out
Pioneer Investments 377,881 sh (-10.72%)
» More
Q3 2014

CTRX Guru Trades in Q3 2014

Jeremy Grantham 1,654,004 sh (New)
Wallace Weitz 1,001,377 sh (+33.76%)
Diamond Hill Capital 476,976 sh (+17.26%)
Manning & Napier Advisors, Inc 5,328,220 sh (+10.49%)
Pioneer Investments 333,535 sh (unchged)
Vanguard Health Care Fund 4,221,183 sh (unchged)
Joel Greenblatt Sold Out
Steven Cohen 270,400 sh (-12.97%)
Paul Tudor Jones 12,455 sh (-20.48%)
Jim Simons 66,600 sh (-83.34%)
» More
Q4 2014

CTRX Guru Trades in Q4 2014

Joel Greenblatt 22,426 sh (New)
Jim Simons 208,970 sh (+213.77%)
Jeremy Grantham 3,028,803 sh (+83.12%)
Paul Tudor Jones 17,792 sh (+42.85%)
Manning & Napier Advisors, Inc 7,315,426 sh (+37.30%)
Vanguard Health Care Fund 4,937,683 sh (+16.97%)
Wallace Weitz 1,162,989 sh (+16.14%)
Pioneer Investments 379,996 sh (+13.93%)
Diamond Hill Capital 505,966 sh (+6.08%)
Steven Cohen Sold Out
» More
Q1 2015

CTRX Guru Trades in Q1 2015

Mario Gabelli 145,800 sh (New)
Paul Tudor Jones 218,880 sh (+1130.22%)
Diamond Hill Capital 590,081 sh (+16.62%)
Pioneer Investments 427,011 sh (+12.37%)
Jeremy Grantham 3,314,869 sh (+9.44%)
Wallace Weitz 1,177,876 sh (+1.28%)
Vanguard Health Care Fund Sold Out
Manning & Napier Advisors, Inc 2,208,429 sh (-69.81%)
Joel Greenblatt 5,390 sh (-75.97%)
Jim Simons 30,000 sh (-85.64%)
» More
» Details

Insider Trades

Latest Guru Trades with CTRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 39.30
CTRX's P/E(ttm) is ranked lower than
128% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. CTRX: 39.30 )
Ranked among companies with meaningful P/E(ttm) only.
CTRX' s 10-Year P/E(ttm) Range
Min: 2.84   Max: 78.05
Current: 39.3

2.84
78.05
Forward P/E 17.04
CTRX's Forward P/E is ranked lower than
160% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. CTRX: 17.04 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 39.30
CTRX's PE(NRI) is ranked lower than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.10 vs. CTRX: 39.30 )
Ranked among companies with meaningful PE(NRI) only.
CTRX' s 10-Year PE(NRI) Range
Min: 2.83   Max: 77.62
Current: 39.3

2.83
77.62
P/B 2.30
CTRX's P/B is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.40 vs. CTRX: 2.30 )
Ranked among companies with meaningful P/B only.
CTRX' s 10-Year P/B Range
Min: 1.58   Max: 8.41
Current: 2.3

1.58
8.41
P/S 0.55
CTRX's P/S is ranked lower than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.47 vs. CTRX: 0.55 )
Ranked among companies with meaningful P/S only.
CTRX' s 10-Year P/S Range
Min: 0.42   Max: 6.67
Current: 0.55

0.42
6.67
PFCF 25.30
CTRX's PFCF is ranked lower than
127% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.50 vs. CTRX: 25.30 )
Ranked among companies with meaningful PFCF only.
CTRX' s 10-Year PFCF Range
Min: 10.38   Max: 97.6
Current: 25.3

10.38
97.6
POCF 22.20
CTRX's POCF is ranked lower than
85% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.46 vs. CTRX: 22.20 )
Ranked among companies with meaningful POCF only.
CTRX' s 10-Year POCF Range
Min: 8.78   Max: 87.5
Current: 22.2

8.78
87.5
EV-to-EBIT 22.86
CTRX's EV-to-EBIT is ranked lower than
95% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. CTRX: 22.86 )
Ranked among companies with meaningful EV-to-EBIT only.
CTRX' s 10-Year EV-to-EBIT Range
Min: 9.9   Max: 64.6
Current: 22.86

9.9
64.6
PEG 0.89
CTRX's PEG is ranked higher than
87% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.54 vs. CTRX: 0.89 )
Ranked among companies with meaningful PEG only.
CTRX' s 10-Year PEG Range
Min: 0.53   Max: 43.6
Current: 0.89

0.53
43.6
Shiller P/E 73.20
CTRX's Shiller P/E is ranked lower than
171% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. CTRX: 73.20 )
Ranked among companies with meaningful Shiller P/E only.
CTRX' s 10-Year Shiller P/E Range
Min: 7.81   Max: 116.44
Current: 73.2

7.81
116.44
Current Ratio 1.38
CTRX's Current Ratio is ranked higher than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.07 vs. CTRX: 1.38 )
Ranked among companies with meaningful Current Ratio only.
CTRX' s 10-Year Current Ratio Range
Min: 0.91   Max: 9.01
Current: 1.38

0.91
9.01
Quick Ratio 1.38
CTRX's Quick Ratio is ranked higher than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.92 vs. CTRX: 1.38 )
Ranked among companies with meaningful Quick Ratio only.
CTRX' s 10-Year Quick Ratio Range
Min: 0.84   Max: 8.99
Current: 1.38

0.84
8.99
Days Sales Outstanding 24.15
CTRX's Days Sales Outstanding is ranked higher than
54% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 24.93 vs. CTRX: 24.15 )
Ranked among companies with meaningful Days Sales Outstanding only.
CTRX' s 10-Year Days Sales Outstanding Range
Min: 17.64   Max: 92.51
Current: 24.15

17.64
92.51

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.80
CTRX's Price/DCF (Projected) is ranked lower than
111% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CTRX: 1.80 )
Ranked among companies with meaningful Price/DCF (Projected) only.
CTRX' s 10-Year Price/DCF (Projected) Range
Min: 1.08   Max: 6.34
Current: 1.8

1.08
6.34
Price/Median PS Value 0.60
CTRX's Price/Median PS Value is ranked higher than
89% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.10 vs. CTRX: 0.60 )
Ranked among companies with meaningful Price/Median PS Value only.
CTRX' s 10-Year Price/Median PS Value Range
Min: 0.21   Max: 6.08
Current: 0.6

0.21
6.08
Price/Peter Lynch Fair Value 1.70
CTRX's Price/Peter Lynch Fair Value is ranked higher than
57% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. CTRX: 1.70 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CTRX' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.29   Max: 4.69
Current: 1.7

0.29
4.69
Earnings Yield (Greenblatt) 4.40
CTRX's Earnings Yield (Greenblatt) is ranked lower than
83% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.90 vs. CTRX: 4.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
CTRX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 10.1
Current: 4.4

1.5
10.1
Forward Rate of Return (Yacktman) 51.33
CTRX's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.45 vs. CTRX: 51.33 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
CTRX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -23.6   Max: 52.5
Current: 51.33

-23.6
52.5

Business Description

Industry: Health Care Plans » Health Care Plans
Compare: » details
Traded in other countries:CCT.Canada,
Catamaran Corp is a provider of pharmacy benefit management services PBM and healthcare IT solutions to the healthcare benefit management industry. The Company's PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail service pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis. The Company owns a mail service pharmacy and a specialty service pharmacy ('Ascend'). PBM services such as pharmacy network management could be provided to the company's customers using the Company's own system software and services. It provides on-line transaction processing solutions through web-enabled, real-time transaction processing technology. The Company's informed Rx offering is a suite of a la carte PBM services that provide a flexible and cost-effective alternative to traditional PBM offerings typically employed by health plans, government agencies and employers. It also provides a pharmacy spend management solutions and information technology capabilities. RxCLAIM (r) is an on-line transaction processing system designed to provide instant on-line adjudication of third-party prescription drug claims at the point of service, including trouble-free claims management and cost-effective review, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider and drug details. RxCLAIM is designed to provide the company's customers with automation efficiencies, flexibility and control by facilitating the real-time processing of pharmacy claims and payments against eligibility, plan benefits, formularies, price, drug utilization review, prior authorization and rebates in addition to many other features. It is also a provider of HCIT solutions and services to providers, payers and other participants in the pharmaceutical supply chain in North America. SXC's product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's solutions are available on a license basis with on-going maintenance and support or on a transaction fee basis using an ASP model. The Company's provider customers include independent, regional chain, institutional, and mail-order pharmacies. It is subject to state and federal statutes and regulations governing the operation of mail service pharmacies and the dispensing of controlled substances.
» More Articles for CTRX

Headlines

Articles On GuruFocus.com
CVS Eyeing Omnicare Acquisition To Bolster Market Position May 23 2015 
UnitedHealth Group Is Ready For A Huge Pharmacy Deal Apr 06 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
UnitedHealth Planning Catamaran Corp’s Acquisition For $12.78 Billion Apr 02 2015 
Gilead Sciences Offering Fresh Wave Of Competition To AbbVie’s Viekira Pak Feb 06 2015 
Wallace Weitz's Partners Value Fund Q2 Commentary Oct 06 2014 
Wallace Weitz's Value Fund Q2 Commentary Oct 06 2014 
Catamaran: A Safe investment for the Future Apr 24 2014 
Stocks Near Their 52-Week Low (Part 1) Apr 04 2014 
Stocks for 2014 - Something for Everyone: Part 1 Jan 10 2014 

More From Other Websites
CATAMARAN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial... May 15 2015
Catamaran Holds Annual and Special Meeting of Shareholders May 14 2015
Catamaran Holds Annual and Special Meeting of Shareholders May 14 2015
CATAMARAN CORP Financials May 08 2015
10-Q for Catamaran Corp. May 06 2015
CATAMARAN CORP Files SEC form 10-Q, Quarterly Report May 04 2015
CATAMARAN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 30 2015
Q1 2015 Catamaran Corp Earnings Release - 06:00 am ET Apr 30 2015
Catamaran Corporation announces strong first quarter financial results Apr 30 2015
Catamaran Corporation announces strong first quarter financial results Apr 30 2015
Script Relief LLC -- Moody's assigns B2 CFR to Script Relief; stable outlook Apr 29 2015
Catamaran to Release 2015 First Quarter Results on April 30, 2015 Apr 23 2015
Catamaran to Release 2015 First Quarter Results on April 30, 2015 Apr 23 2015
Catamaran downgraded by Maxim Group Apr 22 2015
Catamaran's SECURE Generates More Than 70-Percent Reduction in Compound Medication Spend Apr 21 2015
Catamaran's SECURE Generates More Than 70-Percent Reduction in Compound Medication Spend Apr 21 2015
Why Walgreens Won't Buy A PBM Anytime Soon Apr 18 2015
UnitedHealth hikes forecast, shares edge to new heights Apr 16 2015
UnitedHealth hikes forecast, shares edge to new heights Apr 16 2015
UnitedHealth hits all the notes, shares head for new heights Apr 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK